药物保险和牛皮的严重程度:一个回顾性队列研究
Laurence Mainville1, Hélène Veillette1,2, Paul R Fortin3,4
1Division of Dermatology Department of Medicine, CHU de Québec, Université Laval, Québec, Canada.
Journal of health economics and outcomes research
|February 10, 2025
概括
接受先进治疗的牛皮患者在治疗结果上没有差异,无论公共或私人药物保险如何. 这项研究表明,加拿大的牛皮患者可以平等获得护理.
科学领域:
- 皮肤病学 皮肤病学
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 加拿大处方药保险是公共和私人计划的混合体.
- 在公共和私人保险覆盖范围之间,在治疗准入方面可能存在差异.
- 先进的疗法为牛皮提供了新的治疗选择.
研究的目的:
- 为了比较牛皮的严重程度,治疗反应,以及在先进治疗的患者的访问延迟.
- 评估公共和私人药物保险集团之间的差异.
- 评估保险类型对牛皮治疗结果的影响.
主要方法:
- 对接受先进治疗的牛皮患者进行了回顾性队列研究.
- 纳入标准:2015年9月至2019年8月期间由皮肤科医生处方的先进治疗.
- 从北克市一所高等学术护理中心的医疗记录中收集的数据.
主要成果:
- 在公共和私人保险集团之间,牛皮的严重程度或治疗反应没有显著差异.
- 拥有公共保险的患者年龄较大,在社会经济上更贫困,更有可能使用行业的同情计划.
- 高比例的患者 (85.4%) 在难以治疗的部位患有牛皮.
结论:
- 处方医生可以确保公平地获得先进的牛皮治疗方法.
- 保险类型没有证明在获得或护理高级牛皮治疗方面存在不平等.
- 富有同情心的使用计划可以减轻公共保险计划中的潜在进入障碍.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
94
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
94
T Cell Types and Functions
938
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
938
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Inflammatory Bowel Disease IV: Pharmacological Management
99
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
99
Autoimmune Disorders
379
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
379


